AOD-9604
5 mg
Fragment 177-191 (hGH Fragment)
AOD-9604
Modified growth hormone fragment for lipolysis and fat metabolism research.
Prices in AUD. Tax included.
Research Use Only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Description
AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) with an additional tyrosine residue. It was specifically developed to research the fat-reducing effects of growth hormone without the growth-promoting or diabetogenic effects. It has been granted GRAS status by the FDA for use in food products.
Specifications
- SKU
- AOD-5MG
- Size
- 5 mg
- Form
- Lyophilised Powder
- Purity
- >99%
- Storage
- -20°C (lyophilised), 2-8°C (reconstituted)
- Shipping
- Australia Post — 3–5 business days
Research Summary
Research indicates AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue models. Unlike full-length hGH, it does not affect IGF-1 levels or insulin sensitivity in preclinical studies. Its mechanism involves interaction with the beta-3 adrenergic receptor pathway.
Testing Protocol
- HPLC Purity Analysis
- Mass Spectrometry Identity Verification
- Endotoxin Screening (LAL Test)